SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 344 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,621,000 | +98.3% | 34,800 | +300.0% | 0.13% | +74.7% |
| Q2 2019 | $1,322,000 | -10.3% | 8,700 | -35.6% | 0.08% | -21.1% |
| Q4 2018 | $1,473,000 | -63.2% | 13,500 | -55.4% | 0.10% | -41.7% |
| Q2 2018 | $4,005,000 | +17.5% | 30,300 | -34.1% | 0.16% | +19.0% |
| Q1 2018 | $3,408,000 | +104.9% | 46,000 | +53.8% | 0.14% | +85.1% |
| Q4 2017 | $1,663,000 | -65.1% | 29,900 | -78.8% | 0.07% | -70.8% |
| Q2 2017 | $4,763,000 | -0.3% | 141,300 | -12.5% | 0.25% | +15.0% |
| Q1 2017 | $4,777,000 | +582.4% | 161,400 | +1315.8% | 0.22% | -2.7% |
| Q3 2016 | $700,000 | -82.6% | 11,400 | -94.6% | 0.23% | +12.4% |
| Q2 2016 | $4,019,000 | -46.1% | 210,797 | -44.9% | 0.20% | -39.8% |
| Q1 2016 | $7,461,000 | +155.3% | 382,227 | +319.8% | 0.33% | +209.3% |
| Q3 2015 | $2,923,000 | +230.3% | 91,056 | +36.6% | 0.11% | +248.4% |
| Q1 2015 | $885,000 | +107.7% | 66,657 | +126.1% | 0.03% | +93.8% |
| Q4 2014 | $426,000 | -32.3% | 29,485 | -1.2% | 0.02% | -44.8% |
| Q3 2014 | $629,000 | -71.4% | 29,836 | -59.5% | 0.03% | -74.6% |
| Q2 2014 | $2,197,000 | -17.6% | 73,751 | -43.7% | 0.11% | -19.7% |
| Q4 2013 | $2,667,000 | – | 130,965 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |